BrainStorm Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that it has signed a Memorandum of Understanding with PRC Clinical, a Contract Research Organization based in the San Francisco Bay Area, in anticipation of its planned Phase II multi-center ALS clinical trial in the ... (more)
http://www.biospace.com/news_story.aspx?StoryID=301205&full=1
http://www.biospace.com/news_story.aspx?StoryID=301205&full=1
No comments:
Post a Comment